Test 2 Flashcards
Phospholipase A2
Acts on C-2 ester bonds; when acting on phosphatidylinositol, releases arachidonic acid; secreted by pancreas; activity inhibited by glucocorticoids
Phospholipase C
Acts on C-3 ester bond (phosphate bond); found in liver lysosomes and the alpha-toxin of clostridia and other bacilli; activation of membrane phospholipase C activates the PIP2 system
Nieman-pick disease
defect in sphingomyelinase leading to accumulation of sphingomyelin; neurodegenerative course
Tay-Sachs disease
defect in B-hexosaminidase A leading to accumulation of gangliosides; rapid and progressive neurodegeneration, blindess, cherry-red macula
Gaucher disease
most common lysosomal storage disease (Ashkenazi Jews), defect in B-glucocerebrosidase leading to accumulation of glucocerebrosides; hepatosplenomegaly, osteoporosis in long bones; treatable by injection of the enzyme
Zetia (ezetimibe)
acts at small intestine by inhibiting absorption of cholesterol; drug does not enter the bloodstream, block triglycerides or fat-soluble vitamins -> no side effects
Familial hypercholesterolemia
autosomal dominant; mutation in gene encoding for LDL receptor leading to elevated total cholesterol
LDL receptor class 1 mutation
mutation in LDLR promoter (frameshift or splicing) -> no receptors synthesized
LDL receptor class 2 mutation
receptors synthesized but retained in ER or Golgi
LDL receptor class 3 mutation
receptors reach the cell surface but lack normal LDL binding
LDL receptor class 4 mutation
receptors reach the cell surface and bind LDL but are not clustered in coated pits and endocytosed
Cystinuria
autosomal recessive; in the kidney, transporter for cystine, ornithine, arginine, lysine (COAL) is defective; all amino acids are present in the urine and cystine precipitates in the acidic urine forming stones
Hartnup disorder
defective tryptophan absorption causing pellagra-like symptoms (3Ds: dermatitis, diarrhea, dementia in the skin, GI tract, and CNS) as a result of the need for tryptophan and niacin in NAD+ and NADP+ synthesis
Protein malnutrition (Kwashiorkor)
Enough calories, lack protein; failure to gain weight, stunted linear growth, swollen abdomen, skin pigmentation, reddish pigmentation of hair
Increased D-amino acid oxidase (DAO) activity
D-serine is important for NMDA transmission, synaptic plasticity, and development; increased DAO activity catalyzes oxidative deamination of D-amino acids and has been linked to schizophrenia, aging, and neurodegeneration
N-acetylglutamate synthetase (NAGS) deficiency
autosomal recessive; too few cases
carbamoyl phosphate synthetase 1 (CPS1) deficiency
autosomal recessive; develops as early as first day of life; majority die in the neonatal period
ornithine transcarbamoylase (OTC) deficiency
X-linked recessive; most common, causes accumulation of carbamoyl phosphate that can enter the cytosol and participate in pyrimidine synthesis, increasing orotic acid
argininosuccinate synthetase (ASS) deficiency
autosomal recessive; results in citrullinemia, onset between 24-72 hours of life
argininesuccinate lyase (ASL) deficiency
autosomal recessive; 2nd most common urea cycle disorder, leads to argininosuccinic aciduria and abnormally fragile hair
arginase (A1) deficiency
autosomal recessive; rarest UCD, results in argininemia and usually asymptomatic but can suffer progressive spastic diplegia or quadriplegia, intellectual impairment, recurrent vomiting, delay growth, and seizures
Hyperammonemia treatment
Sodium benzoate (glycine), sodium phenylacetate and phenylbutyrate (glutamine), lactulose, arginine and citrulline for deficiencies
Gout
results from hyperuricemia caused by decreased uric acid excretion (~80% cases) or increased uric acid production (~20%, loss regulation of PRPP synthase, amidophosphoribosyl transferase, HG-PRT)
Allopurinol
competitive inhibitor that blocks xanthine oxidase causing a decrease in urate, PRPP and increases xanthine & hypoxanthine